TrialCancer chemotherapy and pharmacology2017

Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway.

Ming-Ming He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.